• About Us
    • Our Company
    • Our People
  • Our Science
    • Our Science
    • Precise Antibody Engineering
    • Cytokine-Fusion Antibody
    • Novel T cell Targets
  • Pipeline
    • Pipeline
    • MMB101
    • MMB102
    • MFA011
  • Partnering
  • News
  • About Us
    • Our Company
    • Our People
  • Our Science
    • Our Science
    • Precise Antibody Engineering
    • Cytokine-Fusion Antibody
    • Novel T cell Targets
  • Pipeline
    • Pipeline
    • MMB101
    • MMB102
    • MFA011
  • Partnering
  • News

  • About us
    • Our Company
    • Our People
  • Contact
  • Home
  • Our Science
    • Cytokine-Fusion Antibody
    • Novel T cell Targets
    • Precise Antibody Engineering
  • Partnering with Us
  • Pipeline
    • MFA011
    • MMB101
    • MMB102

한글 Partnering with Us

MediMabBios business model is focused on open innovation, and we are actively looking for global partners who share our vision and commitment to open innovation.

We are open to explore various collaboration models based on its existing pipeline programs as well as joint research & development opportunities

Contact Us

BD@medimabbio.com

  • Home
  • Our Company
    • Our Company
    • Our People
  • Our Science
    • Our Science
    • Precise Antibody Engineering
    • Cytokine-Fusion Antibody
    • Novel T cell Targets
  • Pipeline
    • Pipeline
    • MMB101
    • MMB102
    • MFA011
  • Partnering with Us
  • News
  • Contact

#721, 54, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea, 13449 Tel. 82-(0)31-623-2100 Fax. 82-(0)31-751-2101 Email. info@medimabbio.com

©MEDIMABBIO. ALL RIGHTS RESERVED.